Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
About this item
Full title
Author / Creator
Maldonado-García, José Luis , García-Mena, Lissette Haydee , Mendieta-Cabrera, Danelia , Pérez-Sánchez, Gilberto , Becerril-Villanueva, Enrique , Alvarez-Herrera, Samantha , Homberg, Toni , Vallejo-Castillo, Luis , Pérez-Tapia, Sonia Mayra , Moreno-Lafont, Martha C , Ortuño-Sahagún, Daniel and Pavón, Lenin
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Major depressive disorder (MDD) is a mood disorder that has become a global health emergency according to the World Health Organization (WHO). It affects 280 million people worldwide and is a leading cause of disability and financial loss. Patients with MDD present immunoendocrine alterations like cortisol resistance and inflammation, which are ass...
Alternative Titles
Full title
Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8d3477dd908f470e93f46162dd88e461
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d3477dd908f470e93f46162dd88e461
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph17070841
